Agios Pharm (AGIO) Insider Trading
- $153,404,205.75
- $155,562,864.87
- Sept. 26, 2024
- Scott Biller
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 1, 2017 | CEO | 6,000 | $61.55 | Sell | $369,300.00 | |
Nov. 14, 2017 | Director | 4,000 | $60.88 | Sell | $243,520.00 | |
Nov. 1, 2017 | Insider | 2,146 | $62.69 | Sell | $134,532.74 | |
Nov. 1, 2017 | CEO | 6,000 | $63.85 | Sell | $383,100.00 | |
Oct. 17, 2017 | Director | 4,000 | $71.10 | Sell | $284,400.00 | |
Oct. 16, 2017 | Director | 1,000 | $71.09 | Sell | $71,090.00 | |
Oct. 4, 2017 | CEO | 80,000 | $70.14 | Sell | $5,611,200.00 | |
Oct. 4, 2017 | Insider | 10,470 | $70.00 | Sell | $732,900.00 | |
Oct. 2, 2017 | CEO | 6,000 | $66.76 | Sell | $400,560.00 | |
Oct. 2, 2017 | Insider | 2,146 | $67.23 | Sell | $144,275.58 | |
Sept. 18, 2017 | CEO | 35,000 | $67.12 | Sell | $2,349,200.00 | |
Sept. 14, 2017 | Director | 4,000 | $65.59 | Sell | $262,360.00 | |
Sept. 13, 2017 | Director | 1,000 | $65.47 | Sell | $65,470.00 | |
Sept. 11, 2017 | Insider | 15,000 | $65.00 | Sell | $975,000.00 | |
Sept. 1, 2017 | Insider | 2,146 | $61.99 | Sell | $133,030.54 | |
Sept. 1, 2017 | CEO | 6,000 | $62.20 | Sell | $373,200.00 | |
Aug. 23, 2017 | Director | 4,000 | $56.85 | Sell | $227,400.00 | |
Aug. 2, 2017 | CEO | 27,000 | $59.95 | Sell | $1,618,650.00 | |
Aug. 2, 2017 | Insider | 23,146 | $59.60 | Sell | $1,379,501.60 | |
July 20, 2017 | Director | 9,000 | $56.36 | Sell | $507,240.00 | |
July 19, 2017 | Director | 3,500 | $56.14 | Sell | $196,490.00 | |
July 7, 2017 | Insider | 2,146 | $55.00 | Sell | $118,030.00 | |
July 3, 2017 | CEO | 3,000 | $51.18 | Sell | $153,540.00 | |
June 21, 2017 | Insider | 4,292 | $55.00 | Sell | $236,060.00 | |
June 14, 2017 | Director | 2,000 | $50.87 | Sell | $101,740.00 | |
June 7, 2017 | CEO | 3,000 | $50.02 | Sell | $150,060.00 | |
May 25, 2017 | Director | 2,036 | $47.10 | Sell | $95,895.60 | |
May 1, 2017 | CEO | 3,000 | $50.06 | Sell | $150,180.00 | |
April 24, 2017 | Major Shareholder | 624,575 | $49.50 | Buy | $30,916,462.50 | |
April 18, 2017 | Director | 5,090 | $54.37 | Sell | $276,743.30 | |
April 17, 2017 | Director | 2,036 | $55.24 | Sell | $112,468.64 | |
April 3, 2017 | CEO | 3,000 | $58.62 | Sell | $175,860.00 | |
April 3, 2017 | Insider | 2,146 | $58.03 | Sell | $124,532.38 | |
March 23, 2017 | Director | 2,036 | $53.11 | Sell | $108,131.96 | |
March 20, 2017 | Insider | 6,438 | $55.00 | Sell | $354,090.00 | |
March 6, 2017 | Director | 40,599 | $50.84 | Sell | $2,064,053.16 | |
Feb. 28, 2017 | Director | 243,082 | $49.36 | Sell | $11,998,527.52 | |
Feb. 23, 2017 | Director | 135,364 | $49.37 | Sell | $6,682,920.68 | |
Feb. 16, 2017 | CEO | 6,000 | $50.01 | Sell | $300,060.00 | |
Oct. 27, 2016 | Director | 2,504 | $48.94 | Sell | $122,545.76 | |
Oct. 5, 2016 | Insider | 5,000 | $55.00 | Sell | $275,000.00 | |
Sept. 28, 2016 | Director | 627 | $54.00 | Sell | $33,858.00 | |
Sept. 27, 2016 | Director | 627 | $54.15 | Sell | $33,952.05 | |
Sept. 20, 2016 | Insider | 5,000 | $50.00 | Sell | $250,000.00 | |
Aug. 30, 2016 | Director | 627 | $36.81 | Sell | $23,079.87 | |
Aug. 29, 2016 | Director | 627 | $37.81 | Sell | $23,706.87 | |
July 26, 2016 | Director | 2,504 | $42.80 | Sell | $107,171.20 | |
July 25, 2016 | Director | 627 | $41.85 | Sell | $26,239.95 | |
June 28, 2016 | Director | 2,504 | $41.88 | Sell | $104,867.52 | |
June 27, 2016 | Director | 627 | $40.37 | Sell | $25,311.99 |
Insiders are both buying and selling Agios Pharm stock.
The insider traders at Agios Pharm are: Scott Biller, David P Schenkein, Lewis Clayton Jr. Cantley, John Duncan Higgons, Glenn Goddard, Christopher Bowden, Steven L Hoerter, Theodore James Jr. Washburn, Carman Alenson, Brian Goff, Jacqualyn A Fouse, James William Burns, John Maraganore, Cecilia Jones, Kaye I Foster-Cheek, Celgene European Investment Co, Robert Nelsen, Darrin Miles, Corp /De/ Celgene, Tsveta Milanova, Sarah Gheuens, and David Scadden
The most active insider trader at Agios Pharm is Scott Biller with 46 trades.
David P Schenkein has sold the most Agios Pharm stock with a total value of $52,693,359.25.
Celgene European Investment Co has bought the most Agios Pharm stock with a total value of $112,876,552.75.
The most recent insider trade for Agios Pharm was on Sept. 26, 2024.
The single biggest insider buy for Agios Pharm was from Corp /De/ Celgene with a total value of $57,027,318.00 on Jan. 23, 2018.
The single biggest insider sell for Agios Pharm was from Robert Nelsen with a total value of $11,998,527.52 on Feb. 28, 2017.